Live from the NIH registry
Studies recruiting near Leesburg right now
Top 25 of 145 recruiting studies, sorted by proximity — each links to its official registry page
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Nature Coast Clinical Research — Inverness, Florida (26.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Florida Retina Institute Wildwood — Wildwood, Florida (11.1 mi)
· Sponsor: Boehringer Ingelheim
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Lady Lake, Florida (10.5 mi)
· Sponsor: Akero Therapeutics, Inc
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Clermont, Florida (16.8 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Lady Lake, Florida (10.5 mi)
· Sponsor: 89bio, Inc.
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
West Orange Endocrinology — Ocoee, Florida (25.4 mi)
· Sponsor: Amgen
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
K2 MEDICAL Research THE VILLAGES — Lady Lake, Florida (10.5 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 410 participants sought
Local Institution - 1040 — The Villages, Florida (12.2 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Wildwood Clinical Research / Florida Retina Institute — Wildwood, Florida (11.1 mi)
· Sponsor: EyeBiotech Ltd.
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Hypercholesterolemia
Phase 2
Interventional 420 participants sought
K2 Medical Research The Villages — The Villages, Florida (12.2 mi)
· Sponsor: Regeneron Pharmaceuticals
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Tavares, Florida (10.6 mi)
· Sponsor: American Society of Clinical Oncology
A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
Type 2 Diabetes
N/A
Observational 2,150 participants sought
Research Site — Leesburg, Florida (3.2 mi)
· Sponsor: AstraZeneca
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Phase 3
Interventional 621 participants sought
Clermont Oncology Center — Clermont, Florida (16.8 mi)
· Sponsor: BioNTech SE
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Health Central — Ocoee, Florida (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Breast Cancer
N/A
Interventional 2,032 participants sought
Lake Medical Imaging — The Villages, Florida (12.2 mi)
· Sponsor: American College of Radiology
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Clermont Oncology Center ( Site 0046) — Clermont, Florida (16.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Charter Research - Lady Lake — The Villages, Florida (12.2 mi)
· Sponsor: Bristol-Myers Squibb
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Non Small Cell Lung Cancer
Phase 3
Interventional 630 participants sought
Florida Cancer Specialists -North - 1125 — The Villages, Florida (12.2 mi)
· Sponsor: OncoC4, Inc.
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
K2 Medical Research - The Villages - Northeast 138th Lane- Site Number : 8400063 — Lady Lake, Florida (10.5 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Health Central — Ocoee, Florida (25.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
K2 Medical Research-Winter Garden — Clermont, Florida (16.8 mi)
· Sponsor: Hoffmann-La Roche
Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry
BPH (Benign Prostatic Hyperplasia)
N/A
Observational 300 participants sought
Avant Concierge Urology — Winter Garden, Florida (23.4 mi)
· Sponsor: Zenflow, Inc.
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
Healthy Participants, Dyslipidemia
Phase 1
Interventional 136 participants sought
Research Site — Inverness, Florida (26.7 mi)
· Sponsor: AstraZeneca